Skip to content

ProMIS Neurosciences Inc.

PMN

CIK 0001374339

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$37.29M
−1,529.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$7.06
−959.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$30.17M
Q1 May 2026
Cash
$63.81M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
8.97M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings